Hypofractionated and intensity-modulated radiotherapy combined with systemic therapy in metastatic hepatocellular carcinoma: A case report

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

612

Figures (1-4)

Sum=689

Publishing Process of This Article

Item

Count

Browse

Download

119

Sum=168

Oct 24, 2024 (publication date) through Nov 28, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. Oct 24, 2024; 15(10): 1342-1350
Published online Oct 24, 2024. doi: 10.5306/wjco.v15.i10.1342

Full Size Figure Download Figure

Figure 4 A-fetoprotein levels. AFP: A-fetoprotein.

Citation: Chen QQ, Chen CQ, Liu JK, Huang MY, Pan M, Huang H. Hypofractionated and intensity-modulated radiotherapy combined with systemic therapy in metastatic hepatocellular carcinoma: A case report. World J Clin Oncol 2024; 15(10): 1342-1350
URL: https://www.wjgnet.com/2218-4333/full/v15/i10/1342.htm
DOI: https://dx.doi.org/10.5306/wjco.v15.i10.1342